Decisions about portfolio attention and claims capacity
Leadership needs to distinguish a change in portfolio composition from a process delay or reporting difference. We identify the cohort comparison or case history required to investigate each question, with appropriate access to the underlying detail.
- Which portfolio segments account for a change in claims experience?
- Where do claims wait between operational stages?
- Which renewal cohorts need a focused investigation?
- How should teams prioritize the identified workflow constraints?
Map the relevant source records
Potential inputs include policy records, premium transactions, claims histories, reserve snapshots and renewal events. Policy amendments and claim status changes can create multiple records for the same entity. We establish the reporting grain, effective dates and join logic with the responsible data owners.
Make reporting definitions visible
A loss ratio needs an agreed claims basis and premium basis. Paid and incurred claims, written and earned premium, and reporting and accident periods should not be treated as interchangeable. Claims cycle time needs explicit start and end events; renewal retention needs an eligible population and outcome window. These choices belong in the metric dictionary and report context.
Validate findings and assign the next review
We reconcile portfolio totals and representative claim histories, then review possible explanations with the responsible business owners. Deliverables can include a driver analysis, evidence gaps and priorities for operational investigation. Tableau views can support the review cadence, with documented definitions, restricted-data access and ownership for follow-up.
Common questions
Can you report both portfolio trends and claims operations?
Yes, with distinct definitions and views for each audience. Case-level access and aggregate portfolio access should be scoped separately.
Does a BI report establish regulatory or actuarial compliance?
No. Any required reporting standard, actuarial interpretation or regulatory approval must be specified and reviewed by your responsible specialists.